CGP 20712 dihydrochloride

Pricing Availability   Qty
Description: Highly potent and selective β1 antagonist
Chemical Name: 1-[2-((3-Carbamoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol dihydrochloride
Purity: ≥96% (HPLC)
Datasheet
Citations (16)
Reviews
Literature (1)

Biological Activity for CGP 20712 dihydrochloride

CGP 20712 dihydrochloride is a highly selective and potent β1-adrenoceptor antagonist (IC50 = 0.7 nM). Displays 10,000-fold selectivity over β2-adrenoceptors.

Technical Data for CGP 20712 dihydrochloride

M. Wt 567.39
Formula C23H25F3N4O5.2HCl
Storage Desiccate at +4°C
Purity ≥96% (HPLC)
CAS Number 1216905-73-5
PubChem ID 56972164
InChI Key PURFQCFKYNMIQF-UHFFFAOYSA-N
Smiles Cl.Cl.CN1C=C(N=C1C1=CC=C(OCC(O)CNCCOC2=CC=C(O)C(=C2)C(N)=O)C=C1)C(F)(F)F

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for CGP 20712 dihydrochloride

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
water 24.72 50

Preparing Stock Solutions for CGP 20712 dihydrochloride

The following data is based on the product molecular weight 567.39. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.5 mM 3.52 mL 17.62 mL 35.25 mL
2.5 mM 0.7 mL 3.52 mL 7.05 mL
5 mM 0.35 mL 1.76 mL 3.52 mL
25 mM 0.07 mL 0.35 mL 0.7 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for CGP 20712 dihydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for CGP 20712 dihydrochloride

References are publications that support the biological activity of the product.

Dooley et al (1986) CGP 20712A: a useful tool for quantitating β1- and β2-adrenoceptors. Eur.J.Pharmacol. 130 137 PMID: 2877892

Hieble et al (1995) α-and β-adrenoceptors. From the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. J.Med.Chem. 38 3415 PMID: 7658428

Kitagawa et al (1995) Determination of β-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective β-antagonists. Br.J.Pharmacol. 116 1635 PMID: 8564230


If you know of a relevant reference for CGP 20712 dihydrochloride, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Adrenergic β1 Receptor Antagonists

Keywords: CGP 20712 dihydrochloride, CGP 20712 dihydrochloride supplier, potent, selective, α1-adrenoceptor, beta1-adrenoceptor, b1-adrenoceptor, β1-Adrenergic, beta1-Adrenergic, b1-adrenergic, antagonist, Receptors, CGP20712, dihydrochloride, CGP, 20712A, CGP20712A, Adrenergic, Beta-1, 1024, Tocris Bioscience

16 Citations for CGP 20712 dihydrochloride

Citations are publications that use Tocris products. Selected citations for CGP 20712 dihydrochloride include:

Ardestani et al (2017) Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology 116 371 PMID: 28089846

Gherbi et al (2014) Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Br J Pharmacol 171 5431 PMID: 25052258

Lemke et al (2008) Unchanged β-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. PLoS One 283 34738 PMID: 18829456

Mistry et al (2013) Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. J Med Chem 56 3852 PMID: 23614528

Lavine et al (2013) Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol 131 376 PMID: 23303344

Lavine (2017) β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression. Invest Ophthalmol Vis Sci 58 299 PMID: 28114591

Littmann et al (2015) Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands. J Biol Chem 355 183 PMID: 26306764

Weiterer et al (2015) Galactomannan and Zymosan Block the Epinephrine-Induced Particle Transport in Tracheal Epithelium. J Neurochem 10 e0143163 PMID: 26571499

Cheng et al (2012) Cytoskeletal role in protection of the failing heart by β-adrenergic blockade. Am J Physiol Heart Circ Physiol 302 H675 PMID: 22081703

Rieg et al (2012) Cardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices. PLoS One 6 e29698 PMID: 22216346

Hott et al (2012) Both α1- and β1-adrenoceptors in the bed nucleus of the stria terminalis are involved in the expression of conditioned contextual fear. Br J Pharmacol 167 207 PMID: 22506532

Sucharov et al (2011) β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. Circulation 17 592 PMID: 21703532

Creed et al (2015) β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res 17 145 PMID: 26607426

Rankovic et al (2011) Modulation of calcium-dependent inactivation of L-type Ca2+ channels via β-adrenergic signaling in thalamocortical relay neurons. PLoS One 6 e27474 PMID: 22164209

Jane-Wit et al (2007) β 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. J Pharmacol Exp Ther 116 399 PMID: 17620508

Crestani et al (2008) Both alpha1 and alpha2-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the bed nucleus of the stria terminal of rats. Br J Pharmacol 153 583 PMID: 18037912


Do you know of a great paper that uses CGP 20712 dihydrochloride from Tocris? Please let us know.

Reviews for CGP 20712 dihydrochloride

There are currently no reviews for this product. Be the first to review CGP 20712 dihydrochloride and earn rewards!

Have you used CGP 20712 dihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.